+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Aldehydes 34035-03-5
34035-03-5,MFCD00195947
Catalog No.:AA003431

34035-03-5 | 5-(4-Chlorophenyl)-2-furaldehyde

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
97%
in stock  
$9.00   $7.00
- +
5g
97%
in stock  
$21.00   $15.00
- +
25g
97%
in stock  
$97.00   $68.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA003431
Chemical Name:
5-(4-Chlorophenyl)-2-furaldehyde
CAS Number:
34035-03-5
Molecular Formula:
C11H7ClO2
Molecular Weight:
206.6251
MDL Number:
MFCD00195947
SMILES:
O=Cc1ccc(o1)c1ccc(cc1)Cl
Properties
Properties
 
BP:
350.7°C at 760 mmHg  
Form:
Solid  
MP:
128-131 °C(lit.)  
Storage:
Inert atmosphere;2-8℃;  

Computed Properties
 
Complexity:
200  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
14  
Hydrogen Bond Acceptor Count:
2  
Rotatable Bond Count:
2  
XLogP3:
3.1  

Upstream Synthesis Route

[1]HeterocyclicCommunications,2003,vol.9,#6,p.625-628

[2]SyntheticCommunications,2005,vol.35,#3,p.333-340

[3]AsianJournalofChemistry,2013,vol.25,#14,p.7738-7742

[4]AsianJournalofChemistry,2017,vol.29,#4,p.735-741

[5]RussianJournalofOrganicChemistry,2009,vol.45,#9,p.1375-1381

[6]JournalofMedicinalChemistry,2009,vol.52,#8,p.2465-2481

[7]Patent:CN108203450,2018,A,.Locationinpatent:Paragraph0030-0033

[8]Patent:CN104449670,2016,B,.Locationinpatent:Paragraph0037;0038;0057

[9]KogyoKagakuZasshi,1950,vol.53,p.81

[10]Chem.Abstr.,1953,p.2164

[11]Mem.Fac.Eng.Kyoto,1952,vol.14,p.195,204

[12]RoczinikiChem.,1953,vol.27,p.54,60

[13]Chem.Abstr.,1954,p.13678

[14]KogyoKagakuZasshi,1950,vol.53,p.81

[15]Chem.Abstr.,1953,p.2164

[16]Mem.Fac.Eng.Kyoto,1952,vol.14,p.195,204

[17]RoczinikiChem.,1953,vol.27,p.54,60

[18]Chem.Abstr.,1954,p.13678

[19]Arzneimittel-Forschung/DrugResearch,1983,vol.33,#10,p.1411-1416

[20]BioorganicandMedicinalChemistryLetters,2007,vol.17,#19,p.5370-5373

[21]EuropeanJournalofMedicinalChemistry,2010,vol.45,#12,p.5576-5584

[22]JournalofAgriculturalandFoodChemistry,2010,vol.58,#5,p.3037-3042

[23]AsianJournalofChemistry,2013,vol.25,#17,p.9595-9600

[24]Patent:CN105777758,2016,A,.Locationinpatent:Paragraph0031;0033

[25]ChemistryofHeterocyclicCompounds,2018,vol.54,#5,p.545-549

[26]Khim.Geterotsikl.Soedin.,2018,vol.54,#5,p.545-549,5

[1]EuropeanJournalofMedicinalChemistry,2017,vol.126,p.929-936

[2]ChemicalBiologyandDrugDesign,2017,vol.89,#4,p.585-598

[1]BioorganicandMedicinalChemistry,2012,vol.20,#21,p.6384-6393,10

[2]OrganicandBiomolecularChemistry,2012,vol.10,#36,p.7402-7417

[1]Organicletters,2001,vol.3,#11,p.1677-1680

[1]Patent:US4882354,1989,A,

Downstream Synthesis Route

[1]HeterocyclicCommunications,2003,vol.9,p.625-628

[2]SyntheticCommunications,2005,vol.35,p.333-340

[3]AsianJournalofChemistry,2013,vol.25,p.7738-7742

[4]AsianJournalofChemistry,2017,vol.29,p.735-741

[5]RussianJournalofOrganicChemistry,2009,vol.45,p.1375-1381

[6]JournalofMedicinalChemistry,2009,vol.52,p.2465-2481

[7]Patent:CN108203450,2018,A.Locationinpatent:Paragraph0030-0033

[8]Patent:CN104449670,2016,B.Locationinpatent:Paragraph0037;0038;0057

[9]KogyoKagakuzasshi/JournaloftheSocietyofChemicalIndustry,1950,vol.53,p.81    Chem.Abstr.,1953,p.2164

[10]KogyoKagakuzasshi/JournaloftheSocietyofChemicalIndustry,1950,vol.53,p.81    Chem.Abstr.,1953,p.2164

[11]Arzneimittel-Forschung/DrugResearch,1983,vol.33,p.1411-1416

[12]BioorganicandMedicinalChemistryLetters,2007,vol.17,p.5370-5373

[13]EuropeanJournalofMedicinalChemistry,2010,vol.45,p.5576-5584

[14]JournalofAgriculturalandFoodChemistry,2010,vol.58,p.3037-3042

[15]AsianJournalofChemistry,2013,vol.25,p.9595-9600

[16]Patent:CN105777758,2016,A.Locationinpatent:Paragraph0031;0033

[17]ChemistryofHeterocyclicCompounds,2018,vol.54,p.545-549    Khim.Geterotsikl.Soedin.,2018,vol.54,p.545-549,5

[1]Malinowski[1953,vol.27,p.54,60][Chem.Abstr.,1954,p.13678]

[2]Du,Xiaohui;Guo,Chun;Hansell,Elizabeth;Doyle,PatriciaS.;Caffrey,ConorR.;Holler,TodP.;McKerrow,JamesH.;Cohen,FredE.[JournalofMedicinalChemistry,2002,vol.45,#13,p.2695-2707]

[1]OrganicLetters,2019

[2]KogyoKagakuzasshi/JournaloftheSocietyofChemicalIndustry,1952,vol.55,p.271    Chem.Abstr.,1954,p.3953

[3]Heterocycles,2011,vol.82,p.1217-1228

[4]JournalofAgriculturalandFoodChemistry,2010,vol.58,p.3037-3042

[1]Bioorganicandmedicinalchemistry,2012,vol.20,p.6384-6393,10

[2]RocznikiChemii,1953,vol.27,p.54,59    Chem.Abstr.,1954,p.13678

[3]KogyoKagakuzasshi/JournaloftheSocietyofChemicalIndustry,1952,vol.55,p.271    Chem.Abstr.,1954,p.3953

[1]CollectionofCzechoslovakChemicalCommunications,1973,vol.38,p.1700-1704

Literature

Title: Design, synthesis, and evaluation of inhibitors for severe acute respiratory syndrome 3C-like protease based on phthalhydrazide ketones or heteroaromatic esters.

Journal: Journal of medicinal chemistry 20070419

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 34035-03-5
13803-39-9

13803-39-9

 56300-69-7

56300-69-7

 34035-04-6

34035-04-6

 52130-34-4

52130-34-4

 22078-59-7

22078-59-7

 34035-05-7

34035-05-7
Building Blocks
More >
Tags:34035-03-5 Molecular Formula|34035-03-5 MDL|34035-03-5 SMILES|34035-03-5 5-(4-Chlorophenyl)-2-furaldehyde |Heterocyclic_Building_Blocks